Literature DB >> 9463589

Expression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis.

E Tolnay1, C Kuhnen, B Voss, T Wiethege, K M Müller.   

Abstract

Vascular endothelial growth factor (VEGF) is a multifunctional cytokine, which has recently been reported to enhance the activation and migration of monocytes through the flt receptor in vitro, which are key events in granuloma formation of granulomatous disorders and in sarcoidosis. Since activated macrophages and monocytes are known to be involved in sarcoid granuloma formation in sarcoidosis, we investigated the expression of VEGF and its receptor flt in 33 paraffin-embedded lung tissue biopsies of patients with pulmonary sarcoidosis. VEGF-mRNA was localized by nonradioactive in situ hybridization, VEGF and flt expression were visualized immunohistochemically. We found an increased transcription and protein production of VEGF and an overexpression of flt in activated alveolar macrophages, in epitheloid cells, and in multinuclear giant cells of pulmonary sarcoid granulomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463589     DOI: 10.1007/s004280050135

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

Review 1.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.

Authors:  S R Boyd; D S W Tan; L de Souza; M H Neale; N E Myatt; R A Alexander; M Robb; J L Hungerford; I A Cree
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function.

Authors:  Tadeusz M Zielonka; U Demkow; E Radzikowska; B Bialas; M Filewska; K Zycinska; M H Obrowski; J Kowalski; K A Wardyn; E Skopinska-Rozewska
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

4.  Angiogenic activity of sera from extrinsic allergic alveolitis patients in relation to clinical, radiological, and functional pulmonary changes.

Authors:  Tadeusz M Zielonka; Urszula Demkow; Małgorzata Filewska; Beata Bialas; Katarzyna Zycinska; Elzbieta Radzikowska; Andrzej K Wardyn; Ewa Skopinska-Rozewska
Journal:  Lung       Date:  2010-07-06       Impact factor: 2.584

5.  Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis.

Authors:  M Sekiya; A Ohwada; K Miura; S Takahashi; Y Fukuchi
Journal:  Lung       Date:  2003       Impact factor: 2.584

6.  Sarcoidosis with high serum levels of vascular endothelial growth factor (VEGF), showing RS3PE-like symptoms in extremities.

Authors:  Masayuki Matsuda; Kumi Sakurai; Tomohisa Fushimi; Kanji Yamamoto; Shiho Rokuhara; Naritoshi Hosaka; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2004-02-11       Impact factor: 2.980

7.  Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis.

Authors:  Seema M Thayil; Thomas A Albini; Hossein Nazari; Andrew A Moshfeghi; Jean-Marie A Parel; Narsing A Rao; Petros C Karakousis
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

Review 8.  Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

Authors:  Andriana I Papaioannou; Konstantinos Kostikas; Panagoula Kollia; Konstantinos I Gourgoulianis
Journal:  Respir Res       Date:  2006-10-17

Review 9.  Angiogenesis in the pathogenesis of inflammatory joint and lung diseases.

Authors:  D A Walsh; C I Pearson
Journal:  Arthritis Res       Date:  2001-02-23

10.  Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients.

Authors:  Argyris Tzouvelekis; Paschalis Ntolios; Andreas Karameris; Anastasios Koutsopoulos; Panagiotis Boglou; Andreas Koulelidis; Kostas Archontogeorgis; George Zacharis; Fotis Drakopanagiotakis; Paschalis Steiropoulos; Stavros Anevlavis; Vlassis Polychronopoulos; Dimitrios Mikroulis; Demosthenes Bouros
Journal:  BMC Res Notes       Date:  2012-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.